Cite
MLA Citation
K Shitara et al.. “REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.” Annals of oncology, vol. 30, 2019, pp. 259–265. http://access.bl.uk/ark:/81055/vdc_100094052283.0x000036